Aaron I. Davis, Director, 10% Owner at Odonate Therapeutics, Inc. (ODT), bought 225,000 shares at $15.20 ($3.4M) on 2020-09-09, disclosed to the SEC on 2020-09-09.
Open-market purchase of $3.4M ODT by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.89 | 125,100 | $1.9M | 55.2% |
| 2 | $14.69 | 18,800 | $276K | 8.2% |
| 3 | $15.20 | 81,100 | $1.2M | 36.6% |
| Total | $14.99 avg | 225,000 | $3.4M | 100% |
| Filing → |
| TYRA | SELL | 2023-02-13 | $4.4M | — | Filing → |
| RAIN | BUY | 2022-11-08 | $11.3M | — | Filing → |
| ITOS | SELL | 2022-05-11 | $20.2M | — | Filing → |